Выпуск
Pharmaceutical Executive Daily: CSL & Alentis Enter $1.6 Billion Global Partnership
Pharmaceutical Executive · 5 октября 2026 г. · 3 мин
Jewel Jones warns that pharma catches patient disengagement too late, CSL and Alentis Therapeutics join Jiangsu Nhwa and Somnivera in a day of new licensing deals, and Corxel's Bo Liang calls GLP-1's leap to bariatric-surgery-level efficacy the biggest surprise in obesity medicine.